Form 4 for VBIO Valion Bio, Inc.
Accepted 2025-09-24 00:00:00 ET · period of report 2025-09-22 · accession 0001683168-25-007223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-24 | 2025-09-22 | VBIO | Ernst Jennifer | CEO, Dir | A - Grant | $0.00 | +22.5K | 23.2K | +3,193% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-22 | A | A | 22,541 | $0.00 | 23,247 | D | — | — |